findmyKOL
Clinical trialNCT00824161TerminatedPhase 2Interventional

Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer

SponsorTaiho Pharmaceutical Co., Ltd.Enrollment28Advanced Colorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate progression free survival primarily. The secondary objectives are to evaluate the antitumor activity, as assessed by objective tumor response, duration of clinical benefit, overall survival, and the safety profile of TAS-109
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Nyu Cancer Institute

    East 34th Street, New York, New York, United States

  • the University of Texas M.D. Anderson Cancer Center

    Holcombe Boulevard, Houston, Texas, United States

  • the Center for Cancer and Blood Disorders

    West Magnolia Avenue, Fort Worth, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

TAS-109
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2009
Primary completion
30 Nov 2009
Completion
31 Dec 2010
Last update posted
23 Apr 2012
Registered enrollment
28
Registry id
NCT00824161
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.